Updated on Jun 30, 2022 | Inside, Research, School
Joseph D. Buxbaum, PhD
Joseph D. Buxbaum, PhD, a pioneering researcher in the field of autism, recently was elected to the National Academy of Medicine, considered one of the highest honors in medicine. New members are elected annually by current active members through a selective process that recognizes individuals who have made major contributions to advance medical sciences, health care, and public health.
A world-renowned molecular geneticist and neurobiologist, Dr. Buxbaum is Professor and Vice Chair for Research in the Department of Psychiatry, and Director of the Seaver Autism Center for Research and Treatment at Icahn School of Medicine at Mount Sinai. He is also Professor of Neuroscience, and Genetics and Genomic Sciences, and the G. Harold and Leila Y. Mathers Research Professor of Geriatrics and Adult Development. (more…)
Nov 7, 2015 | Inside
Eric J. Nestler, MD, PhD
Creating a level playing field, increasing mentorship opportunities, and making inclusion a priority, are among the steps needed to attract more underrepresented minorities and increase the number of women in senior faculty positions in the neurosciences. Those steps were outlined on Friday, September 25, at a Town Hall Meeting on “Diversity in Neuroscience,” attended by an overflow crowd of students and faculty in Hatch Auditorium on the Icahn School of Medicine at Mount Sinai campus. Eric J. Nestler, MD, PhD, Nash Family Professor and Chair, Fishberg Department of Neuroscience, and Director, The Friedman Brain Institute, presented statistics that illustrate the underrepresentation of women at senior faculty ranks in neuroscience departments throughout the country, and how minorities continue to lack equal representation in the sciences. At the Icahn School of Medicine, for example, there are 52 women and 39 male instructors and 386 women and 436 male assistant professors; but at the professor level, there are 79 women and 240 men. And of the 261 faculty members within the Mount Sinai Health System’s eight basic science departments, only 13 are from underrepresented minority groups. These data are equivalent at other leading medical centers around the country. (more…)
Oct 20, 2015 | Inside, Research
The Department of Anesthesiology at the Mount Sinai Health System
Repeated exposure to anesthesia early in life causes changes in emotional behavior that may persist long-term, according to new research from the Icahn School of Medicine at Mount Sinai.
The findings, published in the August 2015 Online First edition of Anesthesiology, mark the first time nonhuman primates have been found to experience long-term behavioral changes resulting from repeated postnatal exposure to anesthesia. Prior results have shown that baby rodents also experience cognitive impairments later in life stemming from early anesthesia exposure. (more…)
Oct 8, 2015 | Inside, Research
Leticia Tordesillas, PhD
Leticia Tordesillas, PhD, and Elizabeth Heller, PhD, are the recipients of the 2015 Robin Chemers Neustein Postdoctoral Fellowship Award, which was created to encourage and support female research scientists at Icahn School of Medicine at Mount Sinai.
Dr. Tordesillas works in the laboratory of Cecilia Berin, PhD, Associate Professor of Pediatrics. Her research is focused on how to establish immune tolerance to foods for the treatment of food allergy. In particular, she is studying how regulatory T cells induced by epicutaneous immunotherapy are generated and suppress anaphylaxis. (more…)
Mar 31, 2015 | Inside, Neuroscience, Research
New research at the Icahn School of Medicine at Mount Sinai sheds light for the first time on how depression and emotional resilience operate on a molecular level. The findings, published in the December 4, 2014, issue of Nature, bring fresh perspective to an area that has eluded researchers for decades by outlining the mechanisms within cells that activate depression and laying the groundwork for new treatments. Current drugs for depression focus on neurotransmitters, or communication between cells, but identification of this novel biochemical pathway could pave the way for more effective drugs with very different mechanisms. (more…)
